{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T00:21:27Z","timestamp":1794183687982,"version":"4.8.0"},"reference-count":35,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>\n                    Humphry Osmond coined the term \u2018psychedelic\u2019 in 1956, conjoining \u2018psyche\u2019 for \u2018soul\u2019 and \u2018delic\u2019 for \u2018to manifest\u2019 or \u2018illuminate\u2019.\n                    <jats:italic toggle=\"yes\">Soul-illumination<\/jats:italic>\n                    is a compound noun that describes a psychological state or process. Osmond intended for it to be a taxonomic noun\u2014naming, not just a state\u2014but a category of drug that can induce this psychological effect as its principal action. Consistent with the etymology of\n                    <jats:italic toggle=\"yes\">psychedelic<\/jats:italic>\n                    , the present work respects the fundamental importance of phenomenology. Accordingly, we examine the main subjective effect of three different psychoactive drugs,\n                    <jats:italic toggle=\"yes\">psilocybin<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">ketamine<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">MDMA (3,4-methylenedioxymethamphetamine)<\/jats:italic>\n                    (variable label,\n                    <jats:italic toggle=\"yes\">Drug<\/jats:italic>\n                    ). Over 200 participants rated Delphi-generated subjective rating scale items based on their personal experiences with all 3 drugs. Factor analyses revealed three or four sufficiently independent dimensions of subjective experience (variable label,\n                    <jats:italic toggle=\"yes\">Effects<\/jats:italic>\n                    ). A machine-learning classifier successfully predicted\n                    <jats:italic toggle=\"yes\">Drug<\/jats:italic>\n                    from\n                    <jats:italic toggle=\"yes\">Effects<\/jats:italic>\n                    , validating the hypothesis that\n                    <jats:italic toggle=\"yes\">psilocybin<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">ketamine<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">MDMA<\/jats:italic>\n                    have categorically distinct subjective effect profiles, differentiable by (1)\n                    <jats:italic toggle=\"yes\">visions<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">psychological insight<\/jats:italic>\n                    (\n                    <jats:italic toggle=\"yes\">psilocybin<\/jats:italic>\n                    ), (2)\n                    <jats:italic toggle=\"yes\">dissociation<\/jats:italic>\n                    (\n                    <jats:italic toggle=\"yes\">ketamine<\/jats:italic>\n                    ) and (3)\n                    <jats:italic toggle=\"yes\">pro-social<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">loving feelings<\/jats:italic>\n                    (\n                    <jats:italic toggle=\"yes\">MDMA<\/jats:italic>\n                    ). We conclude that\n                    <jats:italic toggle=\"yes\">psilocybin<\/jats:italic>\n                    is an exemplar\n                    <jats:italic toggle=\"yes\">psychedelic<\/jats:italic>\n                    \u2014a category of drug definable by the induction of a\n                    <jats:italic toggle=\"yes\">psychedelic state<\/jats:italic>\n                    . The quintessential psychedelic phenomenon is a subjective state characterized by\n                    <jats:italic toggle=\"yes\">visions<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">psychological insight<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.1177\/02698811261464986","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T08:24:27Z","timestamp":1786955067000},"page":"1760-1770","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Defining \u2018psychedelic\u2019"],"prefix":"10.1177","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6050-7258","authenticated-orcid":false,"given":"A. E.","family":"Ostrand","sequence":"first","affiliation":[{"name":"Carhart-Harris Lab, Department of Neurology, University of California San Francisco, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Nour","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Oxford, UK"},{"name":"Max Planck UCL Centre for Computational Psychiatry and Ageing Research, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2281-377X","authenticated-orcid":false,"given":"C.","family":"Timmermann","sequence":"additional","affiliation":[{"name":"UCL Centre for Consciousness Research, Department of Experimental Psychology, University College London, UK"},{"name":"Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1510-6638","authenticated-orcid":false,"given":"A.","family":"Rosati","sequence":"additional","affiliation":[{"name":"Carhart-Harris Lab, Department of Neurology, University of California San Francisco, USA"},{"name":"Department of Psychiatry and Behavioral Sciences, University of California San Francisco, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4773-029X","authenticated-orcid":false,"given":"L. X.","family":"Luan","sequence":"additional","affiliation":[{"name":"Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, UK"},{"name":"Department of Psychology, University of Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gomez-Emilsson","sequence":"additional","affiliation":[{"name":"Qualia Research Institute, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9168-7877","authenticated-orcid":false,"given":"J.","family":"Bornemann","sequence":"additional","affiliation":[{"name":"Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7829-493X","authenticated-orcid":false,"given":"K. T.","family":"Greenway","sequence":"additional","affiliation":[{"name":"Lady Davis Institute, Jewish General Hospital, Montr\u00e9al, QC, Canada"},{"name":"Department of Psychiatry, Faculty of Medicine, McGill University, Montr\u00e9al, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9990-6029","authenticated-orcid":false,"given":"L.","family":"Roseman","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6062-7150","authenticated-orcid":false,"given":"Carhart-Harris","family":"R","sequence":"additional","affiliation":[{"name":"Carhart-Harris Lab, Department of Neurology, University of California San Francisco, USA"},{"name":"Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"crossref","unstructured":"Acevedo EC Uhler S White KP et al. (2025) What predicts beneficial outcomes in psychedelic use? A quantitative content analysis of psychedelic health outcomes. Journal of Psychoactive Drugs 57(2): 193\u2013202. https:\/\/doi.org\/10.1080\/02791072.2024.2314729","DOI":"10.1080\/02791072.2024.2314729"},{"key":"e_1_3_3_3_1","volume-title":"Using the Delphi Method to Establish Expert Consensus: A Practical Guide","author":"Anthony J","year":"2025","unstructured":"Anthony J (2025) Using the Delphi Method to Establish Expert Consensus: A Practical Guide. Palgrave Macmillan."},{"key":"e_1_3_3_4_1","doi-asserted-by":"crossref","unstructured":"Atasoy S Roseman L Kaelen M et al. (2017) Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD. Scientific Reports 7(1): 17661. https:\/\/doi.org\/10.1038\/s41598-017-17546-0","DOI":"10.1038\/s41598-017-17546-0"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1515\/9780773556027"},{"key":"e_1_3_3_6_1","doi-asserted-by":"crossref","unstructured":"Brouwer A Carhart-Harris RL (2020) Pivotal mental states. Journal of Psychopharmacology 35(4): 319\u2013352. https:\/\/doi.org\/10.1177\/0269881120959637","DOI":"10.1177\/0269881120959637"},{"key":"e_1_3_3_7_1","doi-asserted-by":"crossref","unstructured":"Carhart-Harris RL (2018) The entropic brain\u2013revisited. Neuropharmacology 142: 167\u2013178. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.03.010","DOI":"10.1016\/j.neuropharm.2018.03.010"},{"key":"e_1_3_3_8_1","doi-asserted-by":"crossref","unstructured":"Carhart-Harris RL Friston KJ (2019) REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics. Pharmacological Reviews 71(3): 316\u2013344. https:\/\/doi.org\/10.1124\/pr.118.017160","DOI":"10.1124\/pr.118.017160"},{"key":"e_1_3_3_9_1","doi-asserted-by":"crossref","unstructured":"Carhart-Harris RL Leech R Hellyer PJ et al. (2014) The entropic brain: A theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in Human Neuroscience 8: 20. https:\/\/doi.org\/10.3389\/fnhum.2014.00020","DOI":"10.3389\/fnhum.2014.00020"},{"key":"e_1_3_3_10_1","doi-asserted-by":"crossref","unstructured":"Carhart-Harris RL Muthukumaraswamy S Roseman L et al. (2016) Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences of the United States of America 113(17): 4853\u20134858. https:\/\/doi.org\/10.1073\/pnas.1518377113","DOI":"10.1073\/pnas.1518377113"},{"key":"e_1_3_3_11_1","doi-asserted-by":"crossref","unstructured":"Carhart-Harris RL Nutt DJ (2010) User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study. Journal of Substance Use 15(4): 283\u2013300. https:\/\/doi.org\/10.3109\/14659890903271624","DOI":"10.3109\/14659890903271624"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","unstructured":"Carhart-Harris RL Roseman L Haijen E et al. (2018) Psychedelics and the essential importance of context. Journal of Psychopharmacology 32(7): 725\u2013731. https:\/\/doi.org\/10.1177\/0269881118754710","DOI":"10.1177\/0269881118754710"},{"key":"e_1_3_3_13_1","volume-title":"The Mind is Flat: The Illusion of Mental Depth and the Improvised Mind","author":"Chater N","year":"2018","unstructured":"Chater N (2018) The Mind is Flat: The Illusion of Mental Depth and the Improvised Mind. Allen Lane."},{"key":"e_1_3_3_14_1","doi-asserted-by":"crossref","unstructured":"Davis AK Barrett FS So S et al. (2021) Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD. Journal of Psychopharmacology 35(4): 437\u2013446. https:\/\/doi.org\/10.1177\/0269881120967878","DOI":"10.1177\/0269881120967878"},{"key":"e_1_3_3_15_1","doi-asserted-by":"crossref","unstructured":"Diep D de la Salle S Thibault L\u00e9vesque J et al. (2025) The ketamine chameleon: History pharmacology and the contested value of experience. Expert Review of Clinical Pharmacology 18(3): 109\u2013129. https:\/\/doi.org\/10.1080\/17512433.2025.2459377","DOI":"10.1080\/17512433.2025.2459377"},{"key":"e_1_3_3_16_1","doi-asserted-by":"crossref","unstructured":"Ermentrout GB Cowan JD (1979) A mathematical theory of visual hallucination patterns. Biological Cybernetics 34(3): 137\u2013150. https:\/\/doi.org\/10.1007\/BF00336965","DOI":"10.1007\/BF00336965"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.7551\/mitpress\/13711.001.0001"},{"key":"e_1_3_3_18_1","doi-asserted-by":"crossref","unstructured":"Garcia-Romeu A Davis AK Erowid E et al. (2020) Persisting reductions in cannabis opioid and stimulant misuse after naturalistic psychedelic use: An online survey. Frontiers in Psychiatry 10: 955. https:\/\/doi.org\/10.3389\/fpsyt.2019.00955","DOI":"10.3389\/fpsyt.2019.00955"},{"key":"e_1_3_3_19_1","doi-asserted-by":"crossref","unstructured":"Griffiths RR Richards WA McCann U et al. (2006) Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 187(3): 268\u2013283. https:\/\/doi.org\/10.1007\/s00213-006-0457-5","DOI":"10.1007\/s00213-006-0457-5"},{"key":"e_1_3_3_20_1","volume-title":"Realms of the Human Unconscious: Observations from LSD Research","author":"Grof S","year":"1979","unstructured":"Grof S (1979) Realms of the Human Unconscious: Observations from LSD Research. Souvenir Press."},{"key":"e_1_3_3_21_1","doi-asserted-by":"crossref","unstructured":"Gulbinaite R Nazari M Rule ME et al. (2024) Spatiotemporal resonance in mouse primary visual cortex. Current Biology 34(18): 4184\u20134196.e7. https:\/\/doi.org\/10.1016\/j.cub.2024.07.091","DOI":"10.1016\/j.cub.2024.07.091"},{"key":"e_1_3_3_22_1","doi-asserted-by":"crossref","unstructured":"Kugel J Laukkonen RE Yaden DB et al. (2025) Insights on psychedelics: A systematic review of therapeutic effects. Neuroscience & Biobehavioral Reviews 173: 106117. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106117","DOI":"10.1016\/j.neubiorev.2025.106117"},{"key":"e_1_3_3_23_1","doi-asserted-by":"crossref","unstructured":"Lyons T Spriggs M Kerkel\u00e4 L et al. (2024) Human brain changes after first psilocybin use. bioRxiv 2024.10.11.617955. https:\/\/doi.org\/10.1101\/2024.10.11.617955","DOI":"10.1101\/2024.10.11.617955"},{"key":"e_1_3_3_24_1","doi-asserted-by":"crossref","unstructured":"McGovern HT Grimmer HJ Doss MK et al. (2024) An Integrated theory of false insights and beliefs under psychedelics. Communications Psychology 2(1): 69. https:\/\/doi.org\/10.1038\/s44271-024-00120-6","DOI":"10.1038\/s44271-024-00120-6"},{"key":"e_1_3_3_25_1","doi-asserted-by":"crossref","unstructured":"Nichols DE (2016) Psychedelics. Pharmacological Reviews 68(2): 264\u2013355. https:\/\/doi.org\/10.1124\/pr.115.011478","DOI":"10.1124\/pr.115.011478"},{"key":"e_1_3_3_26_1","doi-asserted-by":"crossref","unstructured":"Nichols DE Nichols CD Hendricks PS (2023) Proposed consensus statement on defining psychedelic drugs. Psychedelic Medicine 1(1): 12\u201313. https:\/\/doi.org\/10.1089\/psymed.2022.0008","DOI":"10.1089\/psymed.2022.0008"},{"key":"e_1_3_3_27_1","doi-asserted-by":"crossref","unstructured":"Nutt DJ Erritzoe D Schlag A et al. (2025) A lexicon for psychedelic research and treatment. Drug Science Policy and Law 11: 20503245251380510. https:\/\/doi.org\/10.1177\/20503245251380511","DOI":"10.1177\/20503245251380511"},{"key":"e_1_3_3_28_1","doi-asserted-by":"crossref","unstructured":"Olson DE (2018) Psychoplastogens: A promising class of plasticity-promoting neurotherapeutics. Journal of Experimental Neuroscience 12: 1179069518800508. https:\/\/doi.org\/10.1177\/1179069518800508","DOI":"10.1177\/1179069518800508"},{"key":"e_1_3_3_29_1","doi-asserted-by":"crossref","unstructured":"Osmond H (1957) A review of the clinical effects of psychotomimetic agents. Annals of the New York Academy of Sciences 66(3): 418\u2013434. https:\/\/doi.org\/10.1111\/j.1749-6632.1957.tb40738.x","DOI":"10.1111\/j.1749-6632.1957.tb40738.x"},{"key":"e_1_3_3_30_1","doi-asserted-by":"crossref","unstructured":"Peill JM Trinci KE Kettner H et al. (2022) Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience. Journal of Psychopharmacology 36(1): 31\u201345. https:\/\/doi.org\/10.1177\/02698811211066709","DOI":"10.1177\/02698811211066709"},{"key":"e_1_3_3_31_1","doi-asserted-by":"crossref","unstructured":"Schartner MM Carhart-Harris RL Barrett AB et al. (2017) Increased spontaneous MEG signal diversity for psychoactive doses of ketamine LSD and psilocybin. Scientific Reports 7(1): 46421. https:\/\/doi.org\/10.1038\/srep46421","DOI":"10.1038\/srep46421"},{"key":"e_1_3_3_32_1","doi-asserted-by":"crossref","unstructured":"Siegel JS Subramanian S Perry D et al. (2024) Psilocybin desynchronizes the human brain. Nature 632(8023): 131\u2013138. https:\/\/doi.org\/10.1038\/s41586-024-07624-5","DOI":"10.1038\/s41586-024-07624-5"},{"key":"e_1_3_3_33_1","doi-asserted-by":"crossref","unstructured":"Solmi M Chen C Daure C et al. (2022) A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens entactogens entheogens and dissociative drugs. European Neuropsychopharmacology 64: 44\u201360. https:\/\/doi.org\/10.1016\/j.euroneuro.2022.09.004","DOI":"10.1016\/j.euroneuro.2022.09.004"},{"key":"e_1_3_3_34_1","doi-asserted-by":"crossref","unstructured":"Studerus E Gamma A Vollenweider FX (2010) Psychometric evaluation of the altered states of consciousness rating scale (OAV). PLoS One 5(8): e12412. https:\/\/doi.org\/10.1371\/journal.pone.0012412","DOI":"10.1371\/journal.pone.0012412"},{"key":"e_1_3_3_35_1","doi-asserted-by":"crossref","unstructured":"Taves A (2020) Mystical and other alterations in sense of self: An expanded framework for studying nonordinary experiences. Perspectives on Psychological Science 15(3): 669\u2013690. https:\/\/doi.org\/10.1177\/1745691619895047","DOI":"10.1177\/1745691619895047"},{"key":"e_1_3_3_36_1","doi-asserted-by":"crossref","unstructured":"Timmermann C Bauer PR Gosseries O et al. (2023) A neurophenomenological approach to non-ordinary states of consciousness: Hypnosis meditation and psychedelics. Trends in Cognitive Sciences 27(2): 139\u2013159. https:\/\/doi.org\/10.1016\/j.tics.2022.11.006","DOI":"10.1016\/j.tics.2022.11.006"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811261464986","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811261464986","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811261464986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T23:21:37Z","timestamp":1794180097000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811261464986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1177\/02698811261464986"],"URL":"https:\/\/doi.org\/10.1177\/02698811261464986","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]}}}